Last updated: April 24, 2026
What suppliers manufacture fexofenadine hydrochloride APIs?
Fexofenadine hydrochloride (often sold as the API “fexofenadine” or “fexofenadine hydrochloride”) is produced by established API and intermediate manufacturers with global footprint. Common supplier categories in the fexofenadine supply chain include API manufacturers, specialty chemical makers, and companies that supply registered intermediates and finished API grades under cGMP.
Typical supplier landscape (API + key intermediates)
- API manufacturers (cGMP API scale): supply fexofenadine hydrochloride API or fexofenadine base under DMF or equivalent regulatory dossiers.
- Intermediate suppliers: supply the aryl and piperidine-related intermediates used to build the fexofenadine scaffold.
- Salt-form suppliers: supply the hydrochloride salt form where needed for finished API standardization and downstream tablet formulations.
Commercial procurement reality
- Finished “fexofenadine hydrochloride” API sourcing is usually done through distributors with access to multiple API DMFs, or directly from API plants with established regulatory packages.
- The practical differentiator is not marketing but DMF coverage, impurity profile consistency, and batch release history.
What suppliers manufacture pseudoephedrine hydrochloride APIs?
Pseudoephedrine hydrochloride is a controlled substance precursor in many jurisdictions and is sourced through tightly managed supply chains. API supply typically comes from major specialty/pharma chemical manufacturers and established API plants that operate under robust compliance systems (documentation, chain of custody, and controlled-precursor controls).
Typical supplier landscape (API + controlled-precursor handling)
- API manufacturers (cGMP controlled-substance compliance): supply pseudoephedrine hydrochloride API with regulatory documentation.
- Controlled-precursor intermediate suppliers: supply key intermediates upstream that require licensing and monitoring.
- Conversion/salt-form specialists: supply the hydrochloride salt form for API standardization.
Commercial procurement reality
- The key constraint is compliance capability (licensing, reporting, and tracking), not only manufacturing capacity.
- Procurement often includes additional documentation (end-use statements, regulatory filings, and audit-ready traceability).
How do suppliers break down for these two APIs together?
Supplying both fexofenadine hydrochloride and pseudoephedrine hydrochloride from one procurement stream is possible, but it is usually operationally handled as two lanes:
- Fexofenadine lane: broader set of global API makers.
- Pseudoephedrine lane: narrower set of qualified suppliers due to regulatory controls.
Decision drivers for selecting suppliers
- Regulatory package readiness: DMF/CEP availability, impurity acceptance targets, CoA format.
- Batch consistency: impurity profile and assay ranges across lots.
- Compliance and traceability: for pseudoephedrine, audit trails and controlled-substance handling.
- Lead times and MOQ: pseudoephedrine often has tighter scheduling and batch-based allocations.
Supplier shortlists (what to request in RFP form)
Even when multiple companies can manufacture either API, the commercial shortlist comes from whether the supplier can deliver on the following requirements.
Fexofenadine hydrochloride supplier checklist
- cGMP API manufacture and stable lot-to-lot quality
- DMF (or equivalent regulatory dossier) coverage for your target markets
- Established impurity panel with historical CoA evidence
- Ability to produce required particle size / polymorph form if specified by formulation needs
- Packaging and release documentation (traceable batch records)
Pseudoephedrine hydrochloride supplier checklist
- Licensed manufacturing and controlled-precursor compliance for your destination markets
- Documented chain-of-custody and end-use reporting process
- cGMP manufacture with impurity profile stability
- Ability to supply hydrochloride salt form with consistent assay and residual solvents
- Audit-ready traceability for all controlled handling steps
What suppliers typically exist in the market (practical categories to map)
Because procurement frequently runs through distributor networks with access to multiple API sources, your supplier mapping should be done across these categories:
- Direct API manufacturers (preferable where DMF and change-control history are available)
- Authorized API distributors (faster onboarding; multiple plants under one sales channel)
- CMO-style salt-form or finishing (used when you buy base and convert to hydrochloride)
- Intermediate-to-API vertical suppliers (often stronger on impurity control and continuity of supply)
Key risks that eliminate suppliers fast
For both APIs, suppliers that fail any of these points are typically removed early:
- inconsistent impurity control against your specification
- inability to provide full batch documentation and regulatory dossier support
- change-control gaps that delay tech transfers or require reformulation risk assessment
- for pseudoephedrine, compliance weakness (license limitations, documentation gaps, or inadequate traceability)
Key Takeaways
- Fexofenadine hydrochloride sourcing has a broader supplier set; selection hinges on regulatory dossier readiness, impurity control, and batch consistency.
- Pseudoephedrine hydrochloride sourcing is narrower and compliance-driven; supplier qualification depends on controlled-precursor licensing, chain-of-custody, and traceability.
- Procurement should be structured as two parallel sourcing workstreams with the same quality gate framework, then merged at the product manufacturing stage.
FAQs
-
Can I source fexofenadine hydrochloride and pseudoephedrine hydrochloride from the same supplier?
Sometimes, but most programs source via separate API lanes because pseudoephedrine supplier eligibility is compliance-limited.
-
What matters most for fexofenadine hydrochloride supplier qualification?
Regulatory dossier availability (DMF or equivalent), consistent impurity profile, and documented lot-to-lot batch release.
-
What matters most for pseudoephedrine hydrochloride supplier qualification?
Controlled-precursor licensing, chain-of-custody traceability, and compliance-ready documentation alongside cGMP quality.
-
Do suppliers provide the hydrochloride salt form directly?
Yes for many programs; some supply base with downstream salt formation by the customer or a contract salt-former, depending on regulatory and formulation needs.
-
What is the typical bottleneck in dual-API sourcing?
The pseudoephedrine lane: qualification and allocation cycles usually drive lead times and supplier switching risk.
References
[1] U.S. Drug Enforcement Administration (DEA). Controlled substances and chemical control regulations (pseudoephedrine-related controls). https://www.dea.gov/
[2] European Medicines Agency (EMA). Guidelines and regulatory frameworks related to quality documentation for APIs and pharmaceuticals. https://www.ema.europa.eu/
[3] U.S. Food and Drug Administration (FDA). Drug Master File (DMF) and API-related regulatory guidance. https://www.fda.gov/
